These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report. Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate. Bhattacharjee S; Banerjee M; Pal R Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809 [TBL] [Abstract][Full Text] [Related]
5. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases? Opoka-Winiarska V; Grywalska E; Roliński J BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932 [TBL] [Abstract][Full Text] [Related]
6. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19. Faguer S; Del Bello A; Abravanel F; Nicolau-Travers ML; Kamar N Ann Intern Med; 2020 Sep; 173(6):501-503. PubMed ID: 32432518 [No Abstract] [Full Text] [Related]
10. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis. Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313 [TBL] [Abstract][Full Text] [Related]
11. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report. Shi B; Xia Z; Xiao S; Huang C; Zhou X; Xu H Clin Pediatr (Phila); 2020 Jul; 59(8):823-826. PubMed ID: 32292053 [No Abstract] [Full Text] [Related]
12. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19. Takami A Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895 [No Abstract] [Full Text] [Related]
13. Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis. Xu L; Guo X; Guan H Int J Lab Hematol; 2022 Feb; 44(1):74-81. PubMed ID: 34709704 [TBL] [Abstract][Full Text] [Related]
14. Etoposide-based therapy for severe forms of COVID-19. Hamizi K; Aouidane S; Belaaloui G Med Hypotheses; 2020 Sep; 142():109826. PubMed ID: 32416415 [TBL] [Abstract][Full Text] [Related]
17. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin. Alunno A; Carubbi F; Rodríguez-Carrio J RMD Open; 2020 May; 6(1):. PubMed ID: 32423970 [TBL] [Abstract][Full Text] [Related]
18. Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis. Chan D; Karimi S; Follows G; Torpey N; Suchanek O CEN Case Rep; 2023 Feb; 12(1):27-31. PubMed ID: 35729310 [TBL] [Abstract][Full Text] [Related]